These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2872823)

  • 1. Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia.
    Sorgi PJ; Ratey JJ; Polakoff S
    Am J Psychiatry; 1986 Jun; 143(6):775-6. PubMed ID: 2872823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blockers for aggressive behavior in schizophrenia.
    Am J Psychiatry; 1987 Apr; 144(4):538-9. PubMed ID: 2882699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 4. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 5. Can aggressive behavior in humans be modified by beta blockers?
    Volavka J
    Postgrad Med; 1988 Feb; Spec No():163-8. PubMed ID: 2894657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing angina with beta blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Oct; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
    Ryan RE
    Am Heart J; 1984 Oct; 108(4 Pt 2):1156-9. PubMed ID: 6148878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing and managing akathisia.
    Ratey JJ; Salzman C
    Hosp Community Psychiatry; 1984 Oct; 35(10):975-7. PubMed ID: 6149184
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of impulsive and aggressive behavior with nadolol.
    Polakoff SA; Sorgi PJ; Ratey JJ
    J Clin Psychopharmacol; 1986 Apr; 6(2):125-6. PubMed ID: 3700702
    [No Abstract]   [Full Text] [Related]  

  • 12. Nadolol instead of propranolol?
    Schiff AA
    Am J Psychiatry; 1983 Jul; 140(7):952-3. PubMed ID: 6134475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-aggressive effect of beta-blockers].
    Thibaut F; Colonna L
    Encephale; 1993; 19(3):263-7. PubMed ID: 7903928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of nadolol in coronary disease].
    Tkaczewski W; Goch JH; Dziekański S
    Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
    Jentsch G
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):543-4. PubMed ID: 6124886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon].
    Coumel P; Attuel P; Leclercq JF; Friocourt P
    Arch Mal Coeur Vaiss; 1982 Apr; 75(4):373-87. PubMed ID: 6125139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 19. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.